Analyst Buy Calls: AJANTPHARM, TATACOMM, NMDC in Volatile Market
Analyzing: “Rajesh Palviya of Axis Sec suggests Ajanta Pharma, Tata Communications, NMDC shares to buy today - 15 May” by livemint_markets · 15 May 2026, 10:28 AM IST (about 1 month ago)
What happened
Rajesh Palviya of Axis Securities has issued 'buy' recommendations for Ajanta Pharma, Tata Communications, and NMDC shares for May 15. This guidance comes as the broader Indian market, represented by Sensex and Nifty, saw gains, primarily driven by IT stocks, while oil companies experienced declines.
Why it matters
Analyst recommendations from reputable firms like Axis Securities can influence short-term trading sentiment and stock prices, especially for retail investors. The mixed market performance, with IT leading and oil lagging, highlights sector-specific dynamics that traders need to consider amidst overall volatility.
Impact on Indian markets
AJANTPHARM, TATACOMM, and NMDC are likely to see positive sentiment and potential buying interest due to the analyst's 'buy' call. IT stocks, as a sector, are showing strength, suggesting continued positive momentum. Conversely, oil companies may face selling pressure following recent fuel price hikes, impacting their profitability.
What traders should watch next
Traders should monitor the price action of the recommended stocks for confirmation of the analyst's view. Additionally, keep an eye on the broader market's ability to sustain gains, especially in the IT sector, and watch for further developments in fuel prices and their impact on oil marketing companies.
Key Evidence
- •Rajesh Palviya of Axis Sec suggests Ajanta Pharma, Tata Communications, NMDC shares to buy today - 15 May.
- •Stock market saw gains on May 15, with Sensex rising 451.46 points and Nifty 50 up 143.25 points.
- •Gains were led by IT stocks.
- •Oil companies faced declines after fuel price increases.
- •Market remains volatile within a range of 24,500 to 23,200.
Affected Stocks
Recommended as a buy by a prominent analyst.
Recommended as a buy by a prominent analyst.
Recommended as a buy by a prominent analyst.
People in this Story
Sources and updates
AI-powered analysis by
Anadi Algo News